BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 23927667)

  • 1. Applications of systems biology in cancer immunotherapy: from target discovery to biomarkers of clinical outcome.
    Guhathakurta D; Sheikh NA; Meagher TC; Letarte S; Trager JB
    Expert Rev Clin Pharmacol; 2013 Jul; 6(4):387-401. PubMed ID: 23927667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Challenges and opportunities for oncology biomarker discovery.
    Deyati A; Younesi E; Hofmann-Apitius M; Novac N
    Drug Discov Today; 2013 Jul; 18(13-14):614-24. PubMed ID: 23280501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular biology in medical oncology: diagnosis, prognosis, and precision medicine.
    Aftimos PG; Barthelemy P; Awada A
    Discov Med; 2014 Feb; 17(92):81-91. PubMed ID: 24534471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer omics: from regulatory networks to clinical outcomes.
    Tang B; Hsu PY; Huang TH; Jin VX
    Cancer Lett; 2013 Nov; 340(2):277-83. PubMed ID: 23201140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted therapies of solid cancers: new options, new challenges.
    Awada A; Aftimos PG
    Curr Opin Oncol; 2013 May; 25(3):296-304. PubMed ID: 23493191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genome-scale modeling of human metabolism - a systems biology approach.
    Mardinoglu A; Gatto F; Nielsen J
    Biotechnol J; 2013 Sep; 8(9):985-96. PubMed ID: 23613448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genomic sequencing for cancer diagnosis and therapy.
    Wang L; Wheeler DA
    Annu Rev Med; 2014; 65():33-48. PubMed ID: 24274147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implementing precision medicine initiatives in the clinic: a new paradigm in drug development.
    Hollebecque A; Massard C; Soria JC
    Curr Opin Oncol; 2014 May; 26(3):340-6. PubMed ID: 24709975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platforms for biomarker analysis using high-throughput approaches in genomics, transcriptomics, proteomics, metabolomics, and bioinformatics.
    Merrick BA; London RE; Bushel PR; Grissom SF; Paules RS
    IARC Sci Publ; 2011; (163):121-42. PubMed ID: 22997859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Towards quantitative biology: integration of biological information to elucidate disease pathways and to guide drug discovery.
    Fischer HP
    Biotechnol Annu Rev; 2005; 11():1-68. PubMed ID: 16216773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomics and transcriptomics in drug discovery.
    Dopazo J
    Drug Discov Today; 2014 Feb; 19(2):126-32. PubMed ID: 23773860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Challenges in cancer research and multifaceted approaches for cancer biomarker quest.
    Martinkova J; Gadher SJ; Hajduch M; Kovarova H
    FEBS Lett; 2009 Jun; 583(11):1772-84. PubMed ID: 19327356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Where are we in genomics?
    Hocquette JF
    J Physiol Pharmacol; 2005 Jun; 56 Suppl 3():37-70. PubMed ID: 16077195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Understanding genomic alterations in cancer genomes using an integrative network approach.
    Wang E
    Cancer Lett; 2013 Nov; 340(2):261-9. PubMed ID: 23266571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncoproteomics: current trends and future perspectives.
    Cho WC; Cheng CH
    Expert Rev Proteomics; 2007 Jun; 4(3):401-10. PubMed ID: 17552924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular approaches towards development of purified natural products and their structurally known derivatives as efficient anti-cancer drugs: current trends.
    Saha SK; Khuda-Bukhsh AR
    Eur J Pharmacol; 2013 Aug; 714(1-3):239-48. PubMed ID: 23819913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular markers for cancer prognosis and treatment: have we struck gold?
    Nowsheen S; Aziz K; Panayiotidis MI; Georgakilas AG
    Cancer Lett; 2012 Dec; 327(1-2):142-52. PubMed ID: 22120674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor-associated antigens and biomarkers in cancer and immune therapy.
    Malyankar UM
    Int Rev Immunol; 2007; 26(3-4):223-47. PubMed ID: 17558745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer immunotherapy: accomplishments to date and future promise.
    Helmy KY; Patel SA; Nahas GR; Rameshwar P
    Ther Deliv; 2013 Oct; 4(10):1307-20. PubMed ID: 24116914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.